PHILIP DENNY: Open Payments
NPI 1891346326 · HENRICO, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,580 in 106 payments from 36 companies in 2025. Trend: 2023 $2,168 · 2024 $2,784 · 2025 $2,580
Food & beverage: $2,331Consulting: $150Education: $99
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 10 | $332 |
| ABBVIE INC. | 15 | $328 |
| Janssen Biotech, Inc. | 5 | $228 |
| Alexion Pharmaceuticals, Inc. | 5 | $135 |
| UCB, Inc. | 4 | $114 |
| PFIZER INC. | 4 | $92 |
| Lilly USA, LLC | 5 | $92 |
| Novartis Pharmaceuticals Corporation | 5 | $89 |
| Genentech USA, Inc. | 3 | $87 |
| TG Therapeutics, Inc. | 4 | $81 |
Products named: TYSABRI, QULIPTA, ULTOMIRIS, KESIMPTA, Ocrevus Zunovo, UBRELVY, BOTOX, BRIUMVI.
Industry payments across VA — which companies pay providers there.
